Table 1 Cohort characteristics by appointment completion status and modality amongst patients scheduled for a GI-CREP appointment
| Ā | Appointment Completion (Nā=ā293) | Ā | Type of Appointment Completed (Nā=ā236) | Ā | ||
|---|---|---|---|---|---|---|
Factor | Appointment Completed (Nā=ā236) | Appointment Not Completed (Nā=ā57) | p value | In-Person Office Visit (Nā=ā89) | Telemedicine (Nā=ā147) | p value |
Age, median (IQR) | 49 (37, 60.5) | 54 (44, 65) | 0.064 | 53 (38, 65) | 45 (36, 57) | 0.013 |
Sex | ||||||
Female | 129 (54.7%) | 35 (61.4%) | 0.36 | 50 (56.2%) | 79 (53.7%) | 0.72 |
Male | 107 (45.3%) | 22 (38.6%) | 39 (43.8%) | 68 (46.3%) | ||
Race | ||||||
White | 174 (73.7%) | 38 (66.7%) | 0.22 | 65 (73.0%) | 109 (74.1%) | 0.75 |
Black | 28 (11.9%) | 8 (14.0%) | 9 (10.1%) | 19 (12.9%) | ||
Hispanic | 9 (3.8%) | 0 (0.0%) | 5 (5.6%) | 4 (2.7%) | ||
Asian | 11 (4.7%) | 4 (7.0%) | 5 (5.6%) | 6 (4.1%) | ||
Other | 14 (5.9%) | 7 (12.3%) | 5 (5.6%) | 9 (6.1%) | ||
Marital Status | ||||||
Single | 83 (35.2%) | 22 (38.6%) | 0.63 | 29 (32.6%) | 54 (36.7%) | 0.52 |
Married | 153 (64.8%) | 35 (61.4%) | 60 (67.4%) | 93 (63.3%) | ||
Religion | ||||||
Christian | 115 (48.7%) | 27 (47.4%) | 0.25 | 45 (50.6%) | 70 (47.6%) | 0.24 |
Jewish | 29 (12.3%) | 5 (8.8%) | 14 (15.7%) | 15 (10.2%) | ||
Muslim | 5 (2.1%) | 4 (7.0%) | 3 (3.4%) | 2 (1.4%) | ||
Other | 87 (36.9%) | 21 (36.8%) | 27 (30.3%) | 60 (40.8%) | ||
Insurance | ||||||
Private | 173 (73.3%) | 29 (50.9%) | <ā0.001 | 60 (67.4%) | 113 (76.9%) | 0.19 |
Medicare | 45 (19.1%) | 15 (26.3%) | 22 (24.7%) | 23 (15.6%) | ||
Medicaid | 17 (7.2%) | 9 (15.8%) | 6 (6.7%) | 11 (7.5%) | ||
Other/Unknown | 1 (0.4%) | 4 (7.0%) | 1 (1.1%) | 0 (0.0%) | ||
Distance to Center, median (IQR) | 19.75 (8.8, 33.95) | 21.4 (11.9, 32.7) | 0.30 | 16.3 (7.1, 33.5) | 20.4 (9.6, 34.3) | 0.50 |
Median Income ($), median (IQR) | 82571.5 (66230.5, 106,778) | 93,571 (69,305, 104,928) | 0.51 | 81,519 (64,237, 104,318) | 84,632 (68,224, 107,388) | 0.72 |
Personal History of Cancer | ||||||
No | 147 (62.3%) | 15 (30.0%) | <ā0.001 | 62 (69.7%) | 85 (57.8%) | 0.069 |
Yes | 89 (37.7%) | 35 (70.0%) | 27 (30.3%) | 62 (42.2%) | ||
Referral Reason | ||||||
Personal history of cancer | 80 (33.9%) | 34 (59.6%) | <ā0.001 | 22 (24.7%) | 58 (39.5%) | 0.24 |
Family history of cancer | 85 (36.0%) | 10 (17.5%) | 36 (40.4%) | 49 (33.3%) | ||
Personal history of polyps | 47 (19.9%) | 2 (3.5%) | 21 (23.6%) | 26 (17.7%) | ||
Family history of genetic syndrome | 17 (7.2%) | 2 (3.5%) | 7 (7.9%) | 10 (6.8%) | ||
Other | 7 (3.0%) | 9 (15.8%) | 0 (0.0%) | 0 (0.0%) | ||
Visit Type | Ā | |||||
In-person | 89 (37.7%) | 25 (43.9%) | 0.39 | |||
Telemedicine | 147 (62.3%) | 32 (56.1%) | ||||
Genetic Testing Recommended | ||||||
No | Ā | 5 (5.6%) | 11 (7.5%) | 0.58 | ||
Yes | 84 (94.4%) | 136 (92.5%) | ||||
Consented for Genetic Testing (if recommended) | ||||||
No | Ā | 7 (8.3%) | 10 (7.4%) | ļ»æ0.79 | ||
Yes | 77 (91.7%) | 126 (92.6%) | ||||
Genetic Testing Completed (if consented) | ||||||
No | Ā | 4 (5.2%) | 23 (18.3%) | 0.008 | ||
Yes | 73 (94.8%) | 103 (81.7%) | ||||